Quick Takeaways
- ACORN BIOVENTURES, L.P. filed SCHEDULE 13G/A for Y-mAbs Therapeutics, Inc. Common stock, par value $0.0001 per share (YMAB).
- Disclosed ownership: 7%.
- Date of event: 14 Aug 2025.
ACORN BIOVENTURES, L.P. - 14 Aug 2025 SCHEDULE 13G/A Report for Y-mAbs Therapeutics, Inc. Common stock, par value $0.0001 per share (YMAB)
- Filing Manager
- ACORN BIOVENTURES, L.P.
- Reporting Manager
- Anders Hove
- Symbol
- YMAB
- Shares outstanding
- 44,232,814 shares
- Disclosed Ownership
- 3,096,297 shares
- Ownership
- 7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 Aug 2025, 10:31:34 UTC
- Date of event
- 14 Aug 2025
- Next filing
- 20 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ACORN BIOVENTURES, L.P. disclosed 7% ownership in Y-mAbs Therapeutics, Inc. Common stock, par value $0.0001 per share (YMAB) on 14 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 Aug 2025, 10:31.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ACORN BIOVENTURES, L.P. | 3% | 1,301,686 | 0 | 1,301,686 | Anders Hove | Manager of General Partner | |
| ACORN CAPITAL ADVISORS GP, LLC | 3% | 1,301,686 | 0 | 1,301,686 | Anders Hove | Manager | |
| ACORN BIOVENTURES 2, L.P. | 4% | 1,794,611 | 0 | 1,794,611 | Anders Hove | Manager of General Partner | |
| Acorn Capital Advisors GP 2, LLC | 4% | 1,794,611 | 0 | 1,794,611 | Anders Hove | Manager | |
| Anders Hove | 7% | 3,096,297 | 0 | 3,096,297 | Anders Hove | Individually |